BRETT BRECHNER: Open Payments
NPI 1629079108 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 86 payments from 22 companies in 2025. Trend: 2023 $2,139 · 2024 $1,581 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $425 |
| PFIZER INC. | 8 | $141 |
| Axsome Therapeutics, Inc. | 4 | $117 |
| Novo Nordisk Inc | 6 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Corium, LLC | 3 | $72 |
| Almatica Pharma LLC | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
Products named: VRAYLAR, Auvelity, REXULTI, UBRELVY, NURTEC ODT, CAPLYTA, Azstarys, LOREEV XR.
Industry payments across IN — which companies pay providers there.
